SCHEMBL14528428

SCHEMBL14528428

O=C(OCc1ccccc1)N1CCC[C@H](N2CCCC2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.64
NPC1 O15118 2/20 0.64
RAB9A P51151 2/20 0.64
CYP2C19 P33261 1/20 0.61
TMEM97 Q5BJF2 6/20 0.57
SIGMAR1 Q99720 6/20 0.57
HTR1A P08908 2/20 0.57
HRH2 P25021 2/20 0.57
HRH1 P35367 2/20 0.57
HRH3 Q9Y5N1 2/20 0.57
ADRA2C P18825 1/20 0.57
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CHRM4 P08173 1/20 0.54
CHRM5 P08912 1/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA1D P25100 1/20 0.54
HTR2A P28223 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14528537 1.00 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL14529024 0.96 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL24183442 0.95 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL30738370 0.94 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL13661299 0.94 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL29138124 0.90 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL17695390 0.88 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL22877231 0.88 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL14529819 0.88 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL38659093 0.87 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053495-A2 COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2 MILLENNIUM PHARMACEUTICALS, INC. (US) 2007-05-10 WO disclosed